Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma

scientific article published in November 1990

Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID2208149

P2093author name stringGerber M
Ervin TJ
Hayes DM
Case DC Jr
Dorsk BM
Gams R
P433issue21
P407language of work or nameEnglishQ1860
P304page(s)6833-6835
P577publication date1990-11-01
P1433published inCancer ResearchQ326097
P1476titlePhase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma
P478volume50

Reverse relations

cites work (P2860)
Q36711526Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer
Q40874693Oral idarubicin--an anthracycline derivative with unique properties
Q40889718Oral idarubicin. A review of its pharmacological properties and clinical efficacy in the treatment of haematological malignancies and advanced breast cancer
Q55476413Penetration of idarubicin into malignant brain tumor tissue.
Q41540554Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates

Search more.